Candriam Equities L Biotech.I EUR Acc/ LU1120766032 /
| NAV2024-07-25 | Chg.+25.0698 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,456.6499EUR | +1.03% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | - | - | - | - | - | - | - | - | -11.00 | 9.00 | 8.02 | -2.36 | - |
| 2016 | -22.88 | -4.93 | -1.29 | 3.06 | 8.39 | -8.04 | 11.86 | -2.02 | 2.94 | -10.16 | 12.33 | -2.27 | -17.28% |
| 2017 | 2.99 | 8.66 | -0.73 | -0.63 | -6.06 | 7.75 | -0.77 | 5.59 | 1.39 | -4.99 | -2.01 | 0.83 | +11.43% |
| 2018 | 2.97 | -2.64 | -2.70 | -1.36 | 8.35 | 0.97 | 4.46 | 4.80 | -1.85 | -11.78 | 4.28 | -9.24 | -5.57% |
| 2019 | 12.84 | 4.24 | 0.92 | -4.67 | -4.18 | 7.07 | -0.09 | -1.27 | -3.22 | 7.98 | 13.15 | 0.65 | +36.28% |
| 2020 | -3.94 | -0.26 | -4.88 | 13.11 | 7.67 | 0.44 | -7.71 | -0.21 | 2.72 | -2.15 | 6.96 | 0.76 | +11.20% |
| 2021 | 2.61 | -2.43 | -1.06 | 0.36 | -3.34 | 9.33 | -1.38 | 4.46 | -2.39 | 0.38 | -1.61 | 1.44 | +5.86% |
| 2022 | -9.49 | -2.17 | 6.73 | -2.56 | -4.79 | 5.58 | 7.26 | 2.53 | 0.67 | 6.00 | 1.92 | -6.17 | +3.88% |
| 2023 | 1.21 | -3.40 | -1.97 | 0.66 | 2.31 | -1.05 | -1.18 | 1.42 | -1.89 | -5.97 | 2.68 | 12.11 | +3.96% |
| 2024 | 3.05 | 1.74 | 0.26 | -5.18 | 2.58 | 6.76 | 5.63 | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.15% | 16.06% | 16.41% | 20.29% | 23.10% |
| Sharpe ratio | 1.56 | 1.24 | 1.28 | 0.23 | 0.35 |
| Best month | +12.11% | +6.76% | +12.11% | +12.11% | +13.15% |
| Worst month | -5.18% | -5.18% | -5.97% | -9.49% | -9.49% |
| Maximum loss | -9.49% | -9.49% | -10.38% | -20.59% | -26.96% |
| Outperformance | -3.12% | - | -0.76% | - | - |
All quotes in EUR
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,286.9800 | +22.63% | +17.56% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 243.7100 | +23.94% | +27.10% | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,281.9399 | +20.02% | +9.12% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,456.6499 | +24.63% | +27.49% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,725.7200 | +22.30% | +24.47% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 391.8100 | +22.77% | +28.77% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 360.1900 | +25.10% | +30.50% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 221.7800 | +17.46% | +7.23% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 2,051.3999 | +23.27% | +20.87% | |
| Candriam Equities L Biotechnolog... | reinvestment | 165.2000 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 665.2100 | +21.44% | +15.58% | |
| Candriam Equities L Biotech.I US... | reinvestment | 6,255.2002 | +22.48% | +17.13% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 218.3800 | +19.44% | +8.94% | |
| Candriam Equities L Biotech.R US... | reinvestment | 297.2000 | +22.96% | +19.96% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 228.0600 | +20.44% | +11.65% | |
| Candriam Equities L Biotechnolo... | reinvestment | 934.3600 | +21.88% | +17.02% | |
| Candriam Equities L Biotechnolog... | paying dividend | 853.2800 | +21.84% | +16.91% |
Performance
| YTD | +15.31% | ||
|---|---|---|---|
| 6 Months | +11.13% | ||
| 1 Year | +24.63% | ||
| 3 Years | +27.49% | ||
| 5 Years | +74.33% | ||
| 10 Years | - | ||
| Since start | +63.78% | ||
| Year | |||
| 2023 | +3.96% | ||
| 2022 | +3.88% | ||
| 2021 | +5.86% | ||
| 2020 | +11.20% | ||
| 2019 | +36.28% | ||
| 2018 | -5.57% | ||
| 2017 | +11.43% | ||
| 2016 | -17.28% | ||
